ABEONA THERAPEUTICS INC. (ABEO) › Cash & EquivalentsABEONA THERAPEUTICS INC. (ABEO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $607.0K2010: $7.03M2011: $2.46M2012: $396.0K2013: $424.0K2014: $11.52M2015: $40.14M2016: $69.14M2017: $137.75M2018: $18.75M2019: $129.26M2020: $12.60M2021: $32.94M2022: $14.22M2023: $14.47M2024: $23.36M2025: $78.44M$78.44M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$78.44M+235.8%2024$23.36M+61.4%2023$14.47M+1.8%2022$14.22M-56.8%2021$32.94M+161.5%2020$12.60M-90.3%2019$129.26M+589.4%2018$18.75M-86.4%2017$137.75M+99.2%2016$69.14M+72.3%2015$40.14M+248.4%2014$11.52M+2617.0%2013$424.0K+7.1%2012$396.0K-83.9%2011$2.46M-65.0%2010$7.03M+1058.6%2009$607.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share